130 results on '"Becette, Véronique"'
Search Results
2. Mise à jour 2021 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers infiltrants du sein en France
3. Recommandations du GEFPICS pour la prise en charge des prélèvements dans le cadre du traitement néoadjuvant du cancer du sein
4. Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials
5. Mosaic BRCA1 promoter methylation contribution in hereditary breast/ovarian cancer pedigrees.
6. Mosaic BRCA1promoter methylation contribution in hereditary breast/ovarian cancer pedigrees
7. Adaptive nanopore sequencing to determine pathogenicity of BRCA1 exonic duplication.
8. Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy
9. Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)
10. APCgermline pathogenic variants and epithelial ovarian cancer: causal or coincidental findings?
11. Mise à jour 2014 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers du sein en France
12. Recommandations du GEFPICS concernant la phase pré-analytique pour l’évaluation de HER2 et des récepteurs hormonaux dans le cancer du sein : mise à jour 2014
13. A catalog of numerical centrosome defects in epithelial ovarian cancers
14. APC germline pathogenic variants and epithelial ovarian cancer: causal or coincidental findings?
15. Centrosome amplification favours survival and impairs ovarian cancer progression
16. TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial
17. Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma
18. Une palissade en cache une autre : tumeur inhabituelle du sein chez un homme
19. APCgermline pathogenic variants and epithelial ovarian cancer: causal or coincidental findings?
20. Adaptive nanopore sequencing to determine pathogenicity of BRCA1exonic duplication
21. Rates of upgrade to malignancy for 271 cases of flat epithelial atypia (FEA) diagnosed by breast core biopsy
22. Immunomarker Studies of Fine-Needle Cytopuncture Cell Blocks for Tumor Response Prediction After Preoperative Chemotherapy and Prognosis in Operable Nonmetastatic Primary Breast Carcinoma
23. Co-occurrence of germline BRCA1 and CDH1 pathogenic variants
24. De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor
25. Co-occurrence of germline BRCA1 and CDH1 pathogenic variants.
26. The iron chelator deferasirox synergises with chemotherapy to treat triple-negative breast cancers
27. Additional file 3: of Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)
28. Low centrosome numbers correlate with higher aggressivity in ovarian cancer
29. The role of neoadjuvant chemotherapy in ovarian cancer
30. Co-occurrence of germline BRCA1and CDH1pathogenic variants
31. Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy
32. Abstract 2031: Antitumoral synergy of iron chelators and chemotherapies in triple-negative breast cancer cell lines and patient-derived xenograft
33. Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer
34. Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus‐associated invasive carcinoma
35. Préservation de la fertilité chez les patientes atteintes d’un cancer du col de plus de 2cm
36. Fibromatose mammaire : corrélations anatomo-radio-cliniques et revue de la littérature
37. Histo-genomic stratification reveals the frequent amplification/overexpression ofCCNE1andBRD4genes in non-BRCAness high grade ovarian carcinoma
38. Quiz case. Breast sarcoidosis presenting as a metastatic breast cancer
39. Impact of tumor heterogeneity on disease-free survival in a series of 368 patients treated for a breast cancer
40. Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE 1 and BRD 4 genes in non-BRCAness high grade ovarian carcinoma.
41. Rates of upgrade to malignancy for 271 cases of flat epithelial atypia (FEA) diagnosed by breast core biopsy
42. Retraction—validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
43. RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
44. Erratum: A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
45. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
46. Cytologic diagnosis of lobular carcinoma of the breast
47. Study of the Ki-67 antibody immunolabeling of renal adenocarcinomas with or without renal vein thrombosis
48. Prognostic Value of MIB–1 Antibody Labeling Index to Predict Response to Bacillus Calmette–Guérin Therapy in a High–Risk Selected Population of Patients with Stage T1 Grade G3 Bladder Cancer
49. Dissemination Risk Index Based on Plasminogen Activator System Components in Primary Breast Cancer
50. Study ofFHIT transcripts in normal and malignant breast tissue
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.